Who is sponsoring NCT05217160?

NCT05217160 is sponsored by The Metis Foundation.

What condition does NCT05217160 study?

NCT05217160 studies Wound of Skin, Burns.

What drugs are being tested in NCT05217160?

Interventions: KeraStat® Gel with Morphine application, KeraStat® Gel application.

What is the status of NCT05217160?

NCT05217160 is currently RECRUITING.

Last reviewed 2022-02-01 · How we verify

Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers

NCT05217160 PHASE4 RECRUITING

This study is intended to provide information from subjects who currently have painful, chronically open wounds and assess the pain reduction capacity of KeraStat® Gel with Morphine. In gathering data from subjects who have baseline pain from their chronically open wounds, the investigators can then evaluate the capacity of KeraStat® Gel plus Morphine in reducing the subjects daily pain levels, pain associated with dressing changes, and pain medication consumption.

Details

Lead sponsor	The Metis Foundation
Phase	PHASE4
Status	RECRUITING
Enrolment	24
Start date	Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Wound of Skin
Burns

Interventions

KeraStat® Gel with Morphine application
KeraStat® Gel application

Countries

United States